Ihor Hayduchok: Difference between revisions
Expand source-linked author records; preserve work-specific attribution |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Ihor Hayduchok|English]] · [[Ihor Hayduchok/uk|Українська]] · [[Ihor Hayduchok/es|Español]] · [[Ihor Hayduchok/fr|Français]] · [[Ihor Hayduchok/de|Deutsch]] · [[Ihor Hayduchok/pt|Português]]</div> | |||
'''Ihor Hayduchok''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | '''Ihor Hayduchok''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | ||
Latest revision as of 00:52, 12 November 2026
Ihor Hayduchok is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.
Documented work
Coauthor of a 2021 paper on addiction pharmacotherapy risks and illicit psychoactive-substance circulation during the pandemic.
Research context: Forensic-pharmaceutical analysis and legislative proposals, rather than a controlled treatment trial.
Named collaborators on this work: Valerii Shapovalov.
Identity and evidence notes
The cited 2021 page links ORCID 0000-0003-2897-8417. Later similarly named records have been associated with a different ORCID; this entry does not merge those identities or assert the later record belongs to this author without reconciliation.
Inclusion records authorship of the cited work, not endorsement of every later Vision 2035 proposal. Publication affiliations are historical unless separately updated.
See People and attribution and Research network.